SCHEMBL865098

SCHEMBL865098

CCC(O)c1ccc(N)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
CYP19A1 P11511 2/20 0.44
TAAR1 Q96RJ0 3/20 0.41
TSHR P16473 3/20 0.41
NFKB1 P19838 2/20 0.41
HIF1A Q16665 2/20 0.41
HTR3A P46098 1/20 0.41
PGR P06401 2/20 0.41
TDP1 Q9NUW8 5/20 0.40
ALOX15 P16050 3/20 0.40
KDM4E B2RXH2 2/20 0.40
APEX1 P27695 1/20 0.40
ALDH1A1 P00352 3/20 0.38
AOC3 Q16853 3/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140169 0.94 LMNA (0.54) LMNACYP19A1TAAR1TSHRNFKB1
SCHEMBL1607138 0.87 LMNA (0.75) LMNATAAR1TSHRNFKB1HIF1A
SCHEMBL4035560 0.83 LMNA (0.62) LMNATAAR1HIF1APGRTDP1
SCHEMBL2678379 0.82 CYP19A1 (0.42) LMNACYP19A1TAAR1TSHRNFKB1
SCHEMBL12982553 0.80 ALDH1A1 (0.42) LMNACYP19A1TAAR1TSHRNFKB1
SCHEMBL29861210 0.80 LMNA (0.65) LMNATAAR1TSHRNFKB1HIF1A
SCHEMBL12423876 0.79 LMNA (0.58) LMNATAAR1TSHRNFKB1HIF1A
SCHEMBL5672614 0.79 S1PR2 (0.44) LMNACYP19A1TSHRKDM4EALDH1A1
SCHEMBL10714160 0.78 CYP19A1 (0.46) CYP19A1TAAR1TSHRNFKB1HIF1A
SCHEMBL9729120 0.78 TAAR1 (0.67) LMNACYP19A1TAAR1TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118530557-A High-heat-conductivity plastic for energy-saving LED light source and preparation method thereof 江苏德海汽车科技股份有限公司 2024-08-23 CN claimed
CN-117451808-A Titanium nitride microelectrode array, preparation method and multichannel molecular detection device 上海新微技术研发中心有限公司 2024-01-26 CN claimed
EP-1799791-B1 PHOTOCROSSLINKABLE MATERIALS ROLIC AG (CH) 2016-01-13 EP claimed
CN-101040028-B Photocrosslinkable materials ROLIC AG 2012-03-28 CN claimed
US-7687118-B2 Photocrosslinkable materials ROLIC AG (CH) 2010-03-30 US claimed
US-20080069968-A1 Photocrosslinkable Materials ROLIC AG (CH) 2008-03-20 US claimed
CN-101040028-A Photocrosslinkable materials ROLIC AG (CH) 2007-09-19 CN claimed
EP-1799791-A1 PHOTOCROSSLINKABLE MATERIALS Rolic AG (CH) 2007-06-27 EP claimed
WO-2006039824-A1 PHOTOCROSSLINKABLE MATERIALS ROLIC AG (CH) 2006-04-20 WO claimed
US-4904275-A OXIDIZER L'OREAL (FR) 1990-02-27 US claimed
US-20250180952-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2025-06-05 US disclosed
CN-119798608-A Flame-retardant isocyanate, intrinsic flame-retardant polyurea elastomer and preparation method and application thereof 海洋化工研究院有限公司 2025-04-11 CN disclosed
US-20250041433-A1 PROTEIN-ANTIVIRAL COMPOUND CONJUGATES REGENERON PHARMACEUTICALS, INC. 2025-02-06 US disclosed
EP-4493638-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2025-01-22 EP disclosed
CN-118530557-A High-heat-conductivity plastic for energy-saving LED light source and preparation method thereof 江苏德海汽车科技股份有限公司 2024-08-23 CN disclosed
EP-0411150-B1 INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME OTSUKA PHARMA CO LTD (JP) 1996-11-27 EP disclosed
US-5459142-A Autoimmune disease, atherosclerosis, antiischemic agents and nephritis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-10-17 US disclosed
EP-0511879-B1 Pyrazine derivatives OTSUKA PHARMA CO LTD (JP) 1995-03-22 EP disclosed
US-5238938-A Nephrosis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-08-24 US disclosed
EP-0411150-A1 INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080069968-A1 Photocrosslinkable Materials PARG, VSIR, IGLV6-57 LMNA 2175/4885CYP19A1 3653/4885TAAR1 2107/4885
US-20250041433-A1 PROTEIN-ANTIVIRAL COMPOUND CONJUGATES PARK7, VAMP7, MAVS LMNA 3768/4885CYP19A1 4785/4885TAAR1 4432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.